Skip to content
OpenCapital
Get started

Ligand Pharmaceuticals LGND 1 Year or Less

1 Year or Less at other companies

American International Group logo
American International GroupAIG
$3.89B-7.6%
Popular logo
PopularBPOP
$2.53B+323%
Golub Capital logo
Golub CapitalGBDC
$949.15M—
BGC Group, Inc. logo
BGC Group, Inc.BGC
$20M—
Bank of America logo
Bank of AmericaBAC
$4.32B+320%
Provident Financial Services logo
Provident Financial ServicesPFS
$630.6M+15.7%

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.71B+159%
Enterprise value$5.6B+160%
P/E37.2×—
P/S20.8×+8.7×

Profitability

See full
Gross margin91.9%—
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0×0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's 1 year or less.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's 1 year or less?
Ligand Pharmaceuticals (LGND) reported 1 year or less of $351.07M in Q1 2026.
How has Ligand Pharmaceuticals's 1 year or less changed year-over-year?
Ligand Pharmaceuticals's 1 year or less increased by 181.0% year-over-year, from $124.95M to $351.07M.